在临床上相关的冠状动脉内剂量下,腺的物理化学稳定性,以诱导高血压
Faisal Khalid Y Alsharif1, Harmanjeet Harmanjeet1, Troy Wanandy1,2
1School of Pharmacy and Pharmacology, University of Tasmania, Hobart, Tasmania, Australia.
European journal of hospital pharmacy : science and practice
|February 17, 2026
概括
腺在0.9%的化或5%的乳糖中稳定49天,支持用于冠心内注射的预填注射器. 这通过减少准备延迟,改善了心脏导管工作流程.
科学领域:
- 心血管药理学心血管药理学
- 制药稳定性研究 制药稳定性研究
- 医疗器械制备 医疗器械制备
背景情况:
- 对于冠状动脉内注射的腺的物理化学稳定性尚未得到充分证实.
- 目前的做法涉及现场准备,导致程序延迟和实际挑战.
- 需要稳定的腺溶液,以实现高效的心脏导管程序.
研究的目的:
- 为了评估腺在常用稀释剂中的物理化学稳定性,用于冠心内注射.
- 评估储存温度和持续时间对腺稳定性的影响.
- 为了确定预先制备腺溶液的可行性.
主要方法:
- 使用0.9%的化和5%的乳糖制备了阿诺辛溶液 (12μg/mL).
- 溶液在4°C,25°C和35°C的聚烯注射器中存储长达49天.
- 通过HPLC,pH,视觉检查和颗粒物分析评估稳定性.
主要成果:
- 氨酸溶液在化学上保持稳定,在49天内保持超过97%的初始度.
- 没有观察到显著的物理降解 (颜色变化,颗粒形成,pH值变化).
- 稳定性在两种稀释剂和所有测试的储存温度中都是一致的.
结论:
- 支持先前在0.9%的化或5%的乳糖中制备腺素用于冠心内使用.
- 在经过测试的条件下储存的预填注射器可存活长达49天.
- 这种方法简化了心脏导管,最大限度地减少了延迟,并减少了准备工作量.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
1.7K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
477
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
477
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.6K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.6K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.1K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management
937
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
937
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


